# Securities and Exchange Commission

Type: organization

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/securities-and-exchange-commission-organization
Canonical HTML page: https://getbiobrief.com/entity/securities-and-exchange-commission-organization

## Recent coverage (2 stories)

### Fisher Asset Management Increases Eli Lilly Stake to 4.45M Shares
2026-03-03 00:58:42 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Fisher Asset Management LLC expanded its position in Eli Lilly and Company by 3.5% during the third quarter, acquiring an additional 150,595 shares. This move brings the firm's total holdings to approximately 4.45 million shares, signaling continued institutional confidence in the pharmaceutical giant's growth trajectory.
Full story: https://getbiobrief.com/story/fisher-asset-management-increases-eli-lilly-stake-q3-2026

### Essex Woodlands Trims EyePoint Pharmaceuticals Stake to $15.45 Million
2026-02-28 00:59:04 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Essex Woodlands Management Inc. reduced its position in EyePoint Pharmaceuticals by 7.3% during the third quarter, selling 85,000 shares. Despite the reduction, the firm maintains a high-conviction $15.45 million stake, representing 5% of its total investment portfolio.
Full story: https://getbiobrief.com/story/essex-woodlands-eyepoint-pharmaceuticals-stake-reduction

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.